224 related articles for article (PubMed ID: 24411630)
1. Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Guckenberger M
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):732-8. PubMed ID: 24411630
[TBL] [Abstract][Full Text] [Related]
2. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
[TBL] [Abstract][Full Text] [Related]
3. Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters.
Zhou Z; Folkert M; Cannon N; Iyengar P; Westover K; Zhang Y; Choy H; Timmerman R; Yan J; Xie XJ; Jiang S; Wang J
Radiother Oncol; 2016 Jun; 119(3):501-4. PubMed ID: 27156652
[TBL] [Abstract][Full Text] [Related]
4. Seminal quality prediction using data mining methods.
Sahoo AJ; Kumar Y
Technol Health Care; 2014; 22(4):531-45. PubMed ID: 24898862
[TBL] [Abstract][Full Text] [Related]
5. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function testing after stereotactic body radiotherapy to the lung.
Bishawi M; Kim B; Moore WH; Bilfinger TV
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e107-10. PubMed ID: 21470798
[TBL] [Abstract][Full Text] [Related]
7. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy.
Jayasurya K; Fung G; Yu S; Dehing-Oberije C; De Ruysscher D; Hope A; De Neve W; Lievens Y; Lambin P; Dekker AL
Med Phys; 2010 Apr; 37(4):1401-7. PubMed ID: 20443461
[TBL] [Abstract][Full Text] [Related]
9. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
[TBL] [Abstract][Full Text] [Related]
10. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy.
Adachi T; Nakamura M; Shintani T; Mitsuyoshi T; Kakino R; Ogata T; Ono T; Tanabe H; Kokubo M; Sakamoto T; Matsuo Y; Mizowaki T
Med Phys; 2021 Apr; 48(4):1781-1791. PubMed ID: 33576510
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).
Dehing-Oberije C; Aerts H; Yu S; De Ruysscher D; Menheere P; Hilvo M; van der Weide H; Rao B; Lambin P
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):360-8. PubMed ID: 20888135
[TBL] [Abstract][Full Text] [Related]
16. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.
Ohri N; Werner-Wasik M; Grills IS; Belderbos J; Hope A; Yan D; Kestin LL; Guckenberger M; Sonke JJ; Bissonnette JP; Xiao Y
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e379-84. PubMed ID: 22999272
[TBL] [Abstract][Full Text] [Related]
17. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
18. An improved method of early diagnosis of smoking-induced respiratory changes using machine learning algorithms.
Amaral JL; Lopes AJ; Jansen JM; Faria AC; Melo PL
Comput Methods Programs Biomed; 2013 Dec; 112(3):441-54. PubMed ID: 24001924
[TBL] [Abstract][Full Text] [Related]
19. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
Henderson M; McGarry R; Yiannoutsos C; Fakiris A; Hoopes D; Williams M; Timmerman R
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):404-9. PubMed ID: 18394819
[TBL] [Abstract][Full Text] [Related]
20. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
